Alectinib Drug as Therapy for Advanced Lung Cancer

Advanced non-small cell lung cancer is one of the most common types of lung cancer. Lung cancer occurs when the cells of the lung become abnormal and begin to grow uncontrollably. Alectinib drug could replace crizotinib drug as a first-line of care in treating advanced ALK-positive non-small cell lung cancer.

Related Links